Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773) — Net Asset Momentum
Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773) recorded a net asset momentum of 7.3% as of December 2025, with net assets of CN¥9.27 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check how tangible is Chengdu Kanghong Pharmaceuticals Group C's equity to evaluate the tangible quality of the company's equity base.
YoY Momentum
Current Net Assets
Years of Data
Country
Chengdu Kanghong Pharmaceuticals Group Co Ltd Net Asset Momentum (2009–2025)
This chart tracks Chengdu Kanghong Pharmaceuticals Group Co Ltd's year-over-year net asset growth across 17 annual reporting periods from 2009 to 2025. The most recent momentum reading is +7.3%, with net assets of CN¥9.27 Billion CNY as of December 2025. Read Chengdu Kanghong Pharmaceuticals Group C total liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Chengdu Kanghong Pharmaceuticals Group Co Ltd (2009–2025)
The table below shows the complete annual net asset history for Chengdu Kanghong Pharmaceuticals Group Co Ltd from 2009 to 2025, covering 17 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see 002773 market cap.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥9.27 Billion | CN¥9.92 Billion | CN¥645.22 Million | ▲ +7.3% |
| 2024 | CN¥8.65 Billion | CN¥9.34 Billion | CN¥695.07 Million | ▲ +10.7% |
| 2023 | CN¥7.81 Billion | CN¥8.53 Billion | CN¥717.76 Million | ▲ +13.1% |
| 2022 | CN¥6.91 Billion | CN¥7.72 Billion | CN¥813.85 Million | ▲ +13.1% |
| 2021 | CN¥6.10 Billion | CN¥6.96 Billion | CN¥851.08 Million | ▲ +6.1% |
| 2020 | CN¥5.76 Billion | CN¥7.00 Billion | CN¥1.25 Billion | ▲ +24.6% |
| 2019 | CN¥4.62 Billion | CN¥5.83 Billion | CN¥1.21 Billion | ▲ +13.1% |
| 2018 | CN¥4.08 Billion | CN¥5.19 Billion | CN¥1.11 Billion | ▲ +15.3% |
| 2017 | CN¥3.54 Billion | CN¥4.59 Billion | CN¥1.04 Billion | ▲ +22.0% |
| 2016 | CN¥2.90 Billion | CN¥3.76 Billion | CN¥853.27 Million | ▲ +15.0% |
| 2015 | CN¥2.52 Billion | CN¥2.90 Billion | CN¥376.19 Million | ▲ +56.7% |
| 2014 | CN¥1.61 Billion | CN¥1.94 Billion | CN¥329.11 Million | ▲ +16.0% |
| 2013 | CN¥1.39 Billion | CN¥1.69 Billion | CN¥305.69 Million | ▲ +25.6% |
| 2012 | CN¥1.11 Billion | CN¥1.48 Billion | CN¥375.39 Million | ▲ +18.1% |
| 2011 | CN¥936.39 Million | CN¥1.30 Billion | CN¥359.58 Million | ▲ +49.9% |
| 2010 | CN¥624.85 Million | CN¥991.06 Million | CN¥366.21 Million | ▲ +15.8% |
| 2009 | CN¥539.75 Million | CN¥823.48 Million | CN¥283.73 Million | — |